MilliporeSigma Set To Receive CRISPR Patent.

STAT (2/19, Begley) reports that Merck KGaA subsidiary MilliporeSigma “will soon receive a patent on an invention that increases CRISPR’s efficiency and decreases its off-target effects, according to documents posted this month by the U.S. Patent and Trad...